We are live on
!
Find out more
ACM
Ayer Capital Management Portfolio holdings
AUM
$26.8M
This Fund
S&P 500
This Quarter
Est. Return
+2.11%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$16.9M
AUM Growth
–
Cap. Flow
+$16.6M
Cap. Flow
% of AUM
98.26%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
2
New
2
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELGZ
Celgene Corporation Contingent Value Rights
CELGZ
|
+$12.7M |
| 2 |
ARTC
ARTHROCARE CORP
ARTC
|
+$3.96M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|
Similar funds
OHCM
AC
IT
WA
MCM
ADICC
SC
3NC
Ayer Capital Management's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Ayer Capital Management, which disclosed 2 positions worth $16.9M. Its ten largest holdings account for 100% of the portfolio.
Its largest position is Celgene Corporation Contingent Value Rights: 1,747,375 shares worth $12.9M.
- Ayer Capital Management's largest Q2 2013 buy was Celgene Corporation Contingent Value Rights: 1,747,375 shares worth $12.9M.
- Ayer Capital Management's ten largest holdings make up 100% of its $16.9M portfolio in Q2 2013.
- Ayer Capital Management disclosed 2 positions in Q2 2013, its first 13F filing on record.
Based on Ayer Capital Management's 13F filing for Q2 2013, filed 16 Aug 2013.